Clinical Trial Update: Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity

View source ↗

Summary

A Mayo Clinic-led clinical trial is recruiting to investigate how Type 2 immunity relates to nonalcoholic fatty liver disease (NAFLD) in people with obesity, in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation
• Morbid Obesity
• Nonalcoholic Steatohepatitis

Snippet

Sponsor: Mayo Clinic | Conditions: Obesity, Morbid, NASH - Nonalcoholic Steatohepatitis | Status: RECRUITING